FDA Warning Letter — Trans-Missie B.V.
The FDA took a Warning Letter action against Trans-Missie B.V. on Dec 16, 2025 (Diemen, Netherlands). The action was issued by CDRH and concerns devices products.
Action details
- Facility
- Trans-Missie B.V.
- Date
- Dec 16, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Center
- CDRH
- Location
- Diemen (Netherlands)